Cara Therapeutics, Inc.
Hedge Funds Holdings
Last updated:
Cara Therapeutics, Inc.‘s stocks are currently a part of 175 hedge funds’ portfolios, which represents 62.39% of the total amount of its stocks outstanding. This makes up a total of 31.64M shares of Cara Therapeutics, Inc.. Compared to the previous quarter, the number grew by 4.59% or 1.38M shares more. As for the holding position changes, 26.86% (47) of current hedge fund investors increased the number of shares held, 38.86% (68) of current holders sold a part of the shares held, and 13.71% (24) closed the holdings completely. 26 hedge funds are new holders of Cara Therapeutics, Inc. stock in Q1 2022, it is 14.86% of total holders.
Hedge funds holding Cara Therapeutics (Q2 2017 – Q1 2022)
| Q2 2017 | 125 |
|---|---|
| Q3 2017 | 117 |
| Q4 2017 | 122 |
| Q1 2018 | 116 |
| Q2 2018 | 125 |
| Q3 2018 | 144 |
| Q4 2018 | 132 |
| Q1 2019 | 134 |
| Q2 2019 | 125 |
| Q3 2019 | 141 |
| Q4 2019 | 147 |
| Q1 2020 | 130 |
| Q2 2020 | 142 |
| Q3 2020 | 157 |
| Q4 2020 | 152 |
| Q1 2021 | 166 |
| Q2 2021 | 168 |
| Q3 2021 | 164 |
| Q4 2021 | 176 |
| Q1 2022 | 175 |
Hedge funds changes in Cara Therapeutics positions (Q2 2017 – Q1 2022)
| Q2 2017 | 32 | 46 | 34 | 19 | -6 |
|---|---|---|---|---|---|
| Q3 2017 | 19 | 33 | 41 | 25 | -1 |
| Q4 2017 | 25 | 28 | 38 | 19 | 12 |
| Q1 2018 | 15 | 29 | 35 | 20 | 17 |
| Q2 2018 | 28 | 36 | 32 | 19 | 10 |
| Q3 2018 | 34 | 51 | 26 | 15 | 18 |
| Q4 2018 | 22 | 45 | 37 | 31 | -3 |
| Q1 2019 | 22 | 38 | 42 | 21 | 11 |
| Q2 2019 | 16 | 48 | 28 | 21 | 12 |
| Q3 2019 | 30 | 53 | 35 | 16 | 7 |
| Q4 2019 | 26 | 48 | 41 | 18 | 14 |
| Q1 2020 | 18 | 35 | 44 | 32 | 1 |
| Q2 2020 | 34 | 44 | 28 | 22 | 14 |
| Q3 2020 | 32 | 32 | 48 | 18 | 27 |
| Q4 2020 | 22 | 46 | 48 | 26 | 10 |
| Q1 2021 | 33 | 45 | 51 | 17 | 20 |
| Q2 2021 | 40 | 52 | 50 | 38 | -12 |
| Q3 2021 | 27 | 48 | 53 | 30 | 6 |
| Q4 2021 | 37 | 49 | 53 | 26 | 11 |
| Q1 2022 | 26 | 47 | 68 | 24 | 10 |
Hedge funds changes in Cara Therapeutics stock options (Q2 2017 – Q1 2022)
| Q2 2017 | 20,577,000 | 28,285,000 |
|---|---|---|
| Q3 2017 | 7,099,000 | 10,232,000 |
| Q4 2017 | 4,358,000 | 5,775,000 |
| Q1 2018 | 3,895,000 | 7,031,000 |
| Q2 2018 | 21,713,000 | 14,648,000 |
| Q3 2018 | 20,741,000 | 8,700,000 |
| Q4 2018 | 4,339,000 | 4,756,000 |
| Q1 2019 | 16,328,000 | 13,979,000 |
| Q2 2019 | 20,879,000 | 15,998,000 |
| Q3 2019 | 8,307,000 | 7,961,000 |
| Q4 2019 | 9,224,000 | 7,464,000 |
| Q1 2020 | 6,312,000 | 3,044,000 |
| Q2 2020 | 10,269,000 | 5,078,000 |
| Q3 2020 | 6,168,000 | 3,078,000 |
| Q4 2020 | 15,368,000 | 3,973,000 |
| Q1 2021 | 52,739,000 | 10,191,000 |
| Q2 2021 | 6,089,000 | 5,014,000 |
| Q3 2021 | 9,687,000 | 5,008,000 |
| Q4 2021 | 5,896,000 | 2,714,000 |
| Q1 2022 | 4,349,000 | 1,056,000 |